SSY GROUP (02005) recorded a first-quarter net profit attributable to shareholders of approximately HK$171 million, an increase of 1.6% year-on-year.
Shi Si Medicine Group (02005) released its operating performance for the first quarter of 2026. As of March 31, 2026, the unaudited turnover of the group for the three months ending March 31, 2026 was approximately 1.227 billion Hong Kong dollars, an increase of 8.0% year-on-year. The gross profit was approximately 502 million Hong Kong dollars, a decrease of 1.3% year-on-year, with an unaudited gross profit margin of approximately 41.0%, a decrease of 3.8 percentage points year-on-year. For the three months ended March 31, 2026, the unaudited attributable profit to the company's shareholders was approximately 171,206,000 Hong Kong dollars, an increase of 1.6% year-on-year.
SSY Group (02005) released its business performance for the first quarter of 2026. The group's unaudited revenue for the three months ended March 31, 2026 was approximately HK$1.27 billion, an increase of 8.0% compared to the previous year. Gross profit was approximately HK$502 million, a decrease of 1.3% compared to the previous year, with an unaudited gross profit margin of approximately 41.0%, a decrease of 3.8 percentage points compared to the previous year. For the three months ended March 31, 2026, the group's unaudited net profit attributable to shareholders was approximately HK$171.2 million, an increase of 1.6% compared to the previous year.
Related Articles
.png)
XIAO NOODLES (02408) spent 1.2625 million Hong Kong dollars on May 4 to repurchase 297,500 shares.
On May 4, Taiwan (09890) spent 2.302 million Hong Kong dollars to repurchase 144,200 shares.
SITC (01308) granted 12.639 million shares as rewards.
XIAO NOODLES (02408) spent 1.2625 million Hong Kong dollars on May 4 to repurchase 297,500 shares.
On May 4, Taiwan (09890) spent 2.302 million Hong Kong dollars to repurchase 144,200 shares.
SITC (01308) granted 12.639 million shares as rewards.
